Patent · US Active

Treatment for neoplastic diseases

US10294296B2 · kind B2 · utility

3Cited by
17References
2Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 23, 2011
Grant dateMay 21, 2019
Priority date—
Expiry dateApr 6, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Administration of a mAb that specifically binds IL-1α is useful for treating tumor-associated diseases in human subjects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.